Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.
about
The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugsThe GenoType® MTBDR sl test for resistance to second-line anti-tuberculosis drugsHow can mathematical models advance tuberculosis control in high HIV prevalence settings?Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugsPredictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence communityPopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationThe impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort studyIntegrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South AfricaCost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South AfricaMDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosisHIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study.Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adultsCommunity-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa.Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisEvaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa.Averting epidemics of extensively drug-resistant tuberculosisRapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementationReliability of the MODS assay decentralisation process in three health regions in Peru.Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunitiesA randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania.Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis.Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics.Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.The potential impact of new diagnostic tests on tuberculosis epidemics.Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.The impact of new tuberculosis diagnostics on transmission: why context matters.Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic.An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda.Protocol for a population-based molecular epidemiology study of tuberculosis transmission in a high HIV-burden setting: the Botswana Kopanyo study.Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis.Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsYield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysisExpected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.
P2860
Q24193002-6F2D352E-66F6-4ED6-A506-12667FD75693Q24200646-5E083D83-6207-4FF2-8D0F-3BD868BAA84DQ26824057-49716252-B431-4F53-BD3C-43630A5460E4Q27015848-231DD992-5BDA-4AF8-B376-5070844CC3AEQ28068545-EC0A56F7-D2E4-479D-BA47-EB6E1296F865Q28476641-9AA0FB64-003C-48E6-A53A-C6A671760BA8Q28485280-12B2B580-A7E9-41C7-92F0-5687573B2F07Q28485439-67D313C4-FEB9-4837-8558-512FC79E92DCQ28547001-45C93566-D110-4B6C-A23D-D0C0F33BAB5CQ28554655-0AB95120-7DBD-4A50-88AD-5AD37B291E80Q29247878-EC50F0C5-AB96-485C-9624-DFF17A01A164Q30397119-5903B872-62D2-4F3D-9C57-BAB0C1215FBEQ30433540-DA0E7BB6-E693-45B0-8911-925EDAB80C07Q30856949-B5ACF471-6D26-4429-9697-498CF65B0D97Q33738718-502FE20F-A4E6-4984-BD75-7D7CE88D1228Q33926262-8BA988DF-EC3D-40DC-916B-039F27900FF3Q34224000-B5F01D48-1AC7-4F12-85B9-E00D4B4A94F5Q34395434-B31EDD9E-55E2-4BB8-8A55-0E35A61825ACQ34947034-4FC4A083-5898-476E-8C03-71A76B14B5AEQ34975537-D3F615FD-FDA2-4623-BA99-4CCB25EB9FE8Q34976354-39AE0F14-C059-4527-A19C-DCA222DC5E49Q35012318-39601A8F-A6DB-4FE6-929F-6DFC8BC88386Q35066020-8116883D-33A5-4B02-9BBE-0325E0B7BDFCQ35098082-547B3911-CCF6-4844-A85F-1C3AF1BB3C76Q35268889-D85B3C13-70DD-4D55-9965-B41EDBEDDF51Q35584415-91AA1CD5-1BC0-4BBF-A9EC-E9D06132F28AQ35825395-11955887-FB7E-4D70-B7B1-0F9671241A86Q36066438-2FA0E0D9-7A57-4948-97D8-CA9E3B31012CQ36070976-EA04253C-9FB2-481B-A35D-426AC230A7D8Q36107670-68202965-7929-4791-A2A3-8D3FA913DFD4Q36286134-FC39DEFC-D910-48CF-AD0D-97B3C233D38AQ36316501-1C4E578E-7CE9-4CA3-96C0-ACE393BC9CF1Q36386227-89E14591-187A-41DA-AB70-1786D8136320Q36408928-C25F1B07-F8EB-461D-9414-D20E8BF10E7EQ36486323-CCDECA2B-7EF8-459D-8957-A3FE5929A619Q36920030-2496C352-0165-4751-8643-EC50327426A7Q37151512-F6263555-5C23-4876-A88E-CD0C07299CE7Q37288026-C6EF2EA1-8BEE-444C-8568-DABF939849EFQ37473011-38F19D0A-CC1C-4E7C-9D37-3F454052F5B5Q37675764-94AFA0F2-9607-42D2-A74E-0B9BEF87C671
P2860
Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Impact of enhanced tuberculosi ...... d drug susceptibility testing.
@en
type
label
Impact of enhanced tuberculosi ...... d drug susceptibility testing.
@en
prefLabel
Impact of enhanced tuberculosi ...... d drug susceptibility testing.
@en
P2860
P50
P356
P1476
Impact of enhanced tuberculosi ...... d drug susceptibility testing.
@en
P2093
David W Dowdy
Susan E Dorman
P2860
P304
11293-11298
P356
10.1073/PNAS.0800965105
P407
P577
2008-08-11T00:00:00Z